Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15
Published January 4, 2023 · Recall initiated: December 22, 2022
Summary
FDA records drug Class II recall D-0091-2023, published January 4, 2023 and initiated December 22, 2022. Recalling firm: AVKARE LLC; Status: Completed; Reported quantity: 1237 cartons; Lot: Lot#: 43313, 43342, Exp 12/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed impurities/degradation specifications: Out of specification for unknown impurities.
What to do
Voluntary: Firm initiated · Letter
Get an email if GLYCOPYRROLATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GLYCOPYRROLATE
- Manufacturer
- AVKARE LLC
- Distributor
- USA Nationwide
- Lot
- Lot#: 43313, 43342, Exp 12/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGlycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only,July 29, 2026
- FDAGlycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL, Rx only, Pkg: Precision Dose, Inc, S. Beloil, ILJuly 29, 2026
- FDAGlycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc.,February 4, 2026
- FDAGlycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc.,June 28, 2023
- FDAGanciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGANJanuary 4, 2023
- FDAAlcohol Antiseptic 80% Topical Solution Hand Sanitizer, Non-Sterile Solution, packaged as a a) 2.5 gallonJanuary 4, 2023
Questions about this recall
Was Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15 recalled?
Yes. FDA published recall D-0091-2023 on January 4, 2023. Reported hazard: Failed impurities/degradation specifications: Out of specification for unknown impurities.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GLYCOPYRROLATE.